BroPair Spiromax Európai Unió - magyar - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - salmeterol xinafoate, a flutikazon-propionát - asztma - gyógyszerek obstruktív légúti betegségek, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seffalair Spiromax Európai Unió - magyar - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - asztma - gyógyszerek obstruktív légúti betegségek, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Riltrava Aerosphere Európai Unió - magyar - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - tüdőbetegség, krónikus obstruktív - gyógyszerek obstruktív légúti betegségek, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.